BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19836543)

  • 21. [New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma].
    Gorudko IV; Cherkalina OS; Sokolov AV; Pulina MO; Zakharova ET; Vasil'ev VB; Cherenkevich SN; Panasenko OM
    Bioorg Khim; 2009; 35(5):629-39. PubMed ID: 19915640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood.
    Franck T; Grulke S; Deby-Dupont G; Deby C; Duvivier H; Peters F; Serteyn D
    J Vet Diagn Invest; 2005 Sep; 17(5):412-9. PubMed ID: 16312231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Method for co-purification of equine neutrophil elastase and myeloperoxidase from a limited blood volume.
    de la Rebière de Pouyade G; Serteyn D; Deby-Dupont G; Franck T
    Res Vet Sci; 2009 Dec; 87(3):358-63. PubMed ID: 19409585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms.
    Hoy A; Trégouët D; Leininger-Muller B; Poirier O; Maurice M; Sass C; Siest G; Tiret L; Visvikis S
    Eur J Hum Genet; 2001 Oct; 9(10):780-6. PubMed ID: 11781690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of cholesterol ozonolysis products through an ozone-free mechanism mediated by the myeloperoxidase-H2O2-chloride system.
    Tomono S; Miyoshi N; Sato K; Ohba Y; Ohshima H
    Biochem Biophys Res Commun; 2009 May; 383(2):222-7. PubMed ID: 19345674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
    Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of myeloperoxidase in leukocyte-containing tissues.
    Xia Y; Zweier JL
    Anal Biochem; 1997 Feb; 245(1):93-6. PubMed ID: 9025973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.
    Holvoet P; Cleemput H; Collen D
    Thromb Haemost; 1985 Oct; 54(3):684-7. PubMed ID: 3937265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel assay system for myeloperoxidase activity in whole saliva.
    Sakamoto W; Fujii Y; Kanehira T; Asano K; Izumi H
    Clin Biochem; 2008 May; 41(7-8):584-90. PubMed ID: 18237554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respective role of uraemic toxins and myeloperoxidase in the uraemic state.
    Capeillère-Blandin C; Gausson V; Nguyen AT; Descamps-Latscha B; Drüeke T; Witko-Sarsat V
    Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of secretory products of eosinophils and neutrophils in bronchoalveolar lavage in patients with idiopathic lung fibrosis].
    Pohl WR; Schenk E; Umek H; Micksche M; Kummer F; Köhn H
    Wien Klin Wochenschr; 1993; 105(14):387-92. PubMed ID: 8396288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A myeloperoxidase-specific assay based upon bromide-dependent chemiluminescence of luminol.
    Haqqani AS; Sandhu JK; Birnboim HC
    Anal Biochem; 1999 Aug; 273(1):126-32. PubMed ID: 10452808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis.
    de la Rebière G; Franck T; Deby-Dupont G; Salciccia A; Grulke S; Péters F; Serteyn D
    Vet J; 2008 Oct; 178(1):62-9. PubMed ID: 17942351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
    Takizawa M
    Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
    Van Schooten FJ; Boots AW; Knaapen AM; Godschalk RW; Maas LM; Borm PJ; Drent M; Jacobs JA
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):828-33. PubMed ID: 15159316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut.
    Heeringa P; Foucher P; Klok PA; Huitema MG; Tervaert JW; Weening JJ; Kallenberg CG
    Am J Pathol; 1997 Jul; 151(1):131-40. PubMed ID: 9212739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human neutrophil lipocalin (HNL) and myeloperoxidase (MPO). Studies of lung lavage fluid and lung tissue.
    Schmekel B; Seveus L; Xu SY; Venge P
    Respir Med; 2000 Jun; 94(6):564-8. PubMed ID: 10921760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease.
    Trentini A; Rosta V; Spadaro S; Bellini T; Rizzo P; Vieceli Dalla Sega F; Passaro A; Zuliani G; Gentili V; Campo G; Cervellati C
    Clin Chem Lab Med; 2020 Sep; 58(10):1749-1758. PubMed ID: 32031967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
    Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
    Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.